Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.

Malaria journal - 1 May 2023

Aung Than Htike, Suansomjit Chayanut, Tun Zaw Min, Hlaing Tin Maung, Kaewkungwal Jaranit, Cui Liwang, Sattabongkot Jetsumon, Roobsoong Wanlapa

Abstract excerpt

BACKGROUND: Over the past decade, the incidence of malaria has steadily declined in Myanmar, with Plasmodium vivax becoming predominant. The resilience of P. vivax to malaria control is attributed to the parasite's ability to form hypnozoites in the host's liver, which can cause relapse. Primaquine is used to eliminate hypnozoites but can cause haemolysis in glucose-6-phosphate dehydrogenase (G6PD)-deficient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Glucosephosphate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucosephosphate Dehydrogenase Deficiency

Share to Malaria

Share to Malaria, Vivax

Share to Myanmar

Share to Prevalence

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 37127600
DOI: 10.1186/s12936-023-04559-6
PMCID: PMC10150473

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.PMID 37127600Read ↗

Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.Semantic proximity Read ↗

Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>A) is the most common variant in the Myanmar population.Semantic proximity Read ↗

Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.Semantic proximity Read ↗

Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.Semantic proximity Read ↗

G6PD deficiency in malaria endemic areas of Nepal.Semantic proximity Read ↗

Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.Semantic proximity Read ↗

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, BangladeshSemantic proximity Read ↗

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity Read ↗

Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar borderSemantic proximity Read ↗

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity Read ↗

Clinical Performance of the STANDARD™ G6PD Test in IndiaSemantic proximity Read ↗

Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.